Medline, Inc. (MDLN)
34.69
+0.43
(+1.26%)
USD |
NASDAQ |
Aug 24, 16:00
34.70
+0.01
(+0.03%)
After-Hours: 20:00
Medline Price to Book Value : 2.629 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 2.596 |
| August 20, 2026 | 2.469 |
| August 19, 2026 | 2.570 |
| August 18, 2026 | 2.586 |
| August 17, 2026 | 2.643 |
| August 14, 2026 | 2.709 |
| August 13, 2026 | 2.696 |
| August 12, 2026 | 2.690 |
| August 11, 2026 | 2.656 |
| August 10, 2026 | 2.562 |
| August 07, 2026 | 2.67 |
| August 06, 2026 | 2.615 |
| August 05, 2026 | 2.779 |
| August 04, 2026 | 3.186 |
| August 03, 2026 | 3.067 |
| July 31, 2026 | 2.977 |
| July 30, 2026 | 2.965 |
| July 29, 2026 | 3.038 |
| July 28, 2026 | 3.070 |
| July 27, 2026 | 3.009 |
| July 24, 2026 | 2.937 |
| July 23, 2026 | 2.852 |
| July 22, 2026 | 2.818 |
| July 21, 2026 | 2.962 |
| July 20, 2026 | 2.947 |
| Date | Value |
|---|---|
| July 17, 2026 | 3.016 |
| July 16, 2026 | 3.116 |
| July 15, 2026 | 2.989 |
| July 14, 2026 | 2.930 |
| July 13, 2026 | 3.075 |
| July 10, 2026 | 3.110 |
| July 09, 2026 | 3.096 |
| July 08, 2026 | 3.054 |
| July 07, 2026 | 3.260 |
| July 06, 2026 | 3.240 |
| July 02, 2026 | 3.273 |
| July 01, 2026 | 3.163 |
| June 30, 2026 | 2.989 |
| June 29, 2026 | 2.973 |
| June 26, 2026 | 2.917 |
| June 25, 2026 | 2.835 |
| June 24, 2026 | 2.706 |
| June 23, 2026 | 2.649 |
| June 22, 2026 | 2.605 |
| June 18, 2026 | 2.697 |
| June 17, 2026 | 2.733 |
| June 16, 2026 | 2.784 |
| June 15, 2026 | 2.802 |
| June 12, 2026 | 2.748 |
| June 11, 2026 | 2.787 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ICU Medical, Inc. | 2.122 |
| Insulet Corp. | 7.101 |
| Abbott Laboratories | 3.950 |
| AngioDynamics, Inc. | 3.852 |
| Alphatec Holdings, Inc. | -- |
Price to Book Value Related Metrics
| PE Ratio | 40.68 |
| PS Ratio | 0.9552 |
| Price to Free Cash Flow | 18.50 |
| Price | 34.69 |
| Earnings Yield | 2.46% |
| Market Cap | 30.42B |
| Operating PE Ratio | 14.69 |
| Normalized PE Ratio | 25.79 |